180 Life Sciences Announces The Appointment Of Omar Jimenez As Chief Financial Officer, Effective September 30, 2024
180 Life Sciences Announces The Appointment Of Omar Jimenez As Chief Financial Officer, Effective September 30, 2024
180 Life Sciences Corp. ("180" or the "Company") is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effective September 30, 2024. Mr. Jimenez, already a director of the Company, will play a key role in driving the financial strategy of the Company as it continues to grow and innovate in the pharma and biotechnology sectors.
180 生命科學公司（「180」 或 「公司」）欣然宣佈，任命奧馬爾·希門尼斯爲新任首席財務官，自2024年9月30日起生效。希門尼斯先生已經是公司董事，隨着公司在製藥和生物技術領域的持續發展和創新，他將在推動公司的財務戰略方面發揮關鍵作用。
"We are excited to have Omar stepping onto our executive team," said Mr. Blair Jordan, CEO of 180. "His extensive financial expertise, combined with his forward-thinking approach, makes him the ideal CFO to guide us through this exciting chapter of growth and transformation for the Company."
180首席執行官布萊爾·喬丹說：「我們很高興奧馬爾加入我們的執行團隊。」「他豐富的財務專業知識與前瞻性思維方法相結合，使他成爲指導我們度過公司這一激動人心的成長和轉型篇章的理想首席財務官。」
譯文內容由第三人軟體翻譯。
